• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 3. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Professional Introduction to 3-Bromo-5-fluoropyridine-2-carboxylic acid (CAS No: 1189513-55-0)

3-Bromo-5-fluoropyridine-2-carboxylic acid, identified by the Chemical Abstracts Service Number (CAS No) 1189513-55-0, is a significant intermediate in modern pharmaceutical and agrochemical research. This compound belongs to the pyridine family, characterized by a nitrogen-containing heterocyclic ring, which makes it a versatile scaffold for drug discovery. The presence of both bromine and fluorine substituents enhances its reactivity, making it a valuable building block for synthesizing more complex molecules.

The structural features of 3-Bromo-5-fluoropyridine-2-carboxylic acid contribute to its broad utility in medicinal chemistry. The bromo group at the 3-position allows for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, enabling the introduction of aryl or amino groups. Meanwhile, the fluorine atom at the 5-position provides electronic and steric effects that can modulate binding affinity and metabolic stability in drug candidates. The carboxylic acid moiety at the 2-position offers opportunities for amide bond formation, a common strategy in drug design to improve solubility and bioavailability.

In recent years, 3-Bromo-5-fluoropyridine-2-carboxylic acid has garnered attention in the development of targeted therapies. Its pyridine core is a privileged structure found in numerous approved drugs, including antiviral, anticancer, and anti-inflammatory agents. For instance, studies have demonstrated its role in synthesizing kinase inhibitors, where the bromo and fluorine substituents fine-tune interactions with protein targets. The compound’s ability to serve as a precursor for heterocyclic derivatives has been exploited in designing molecules with enhanced pharmacokinetic profiles.

One notable application of 3-Bromo-5-fluoropyridine-2-carboxylic acid is in the synthesis of small-molecule probes for biochemical assays. Researchers have leveraged its reactivity to develop tools that interrogate signaling pathways involving tyrosine kinases and other enzymes relevant to diseases such as cancer and immunodeficiencies. The compound’s fluorinated nature also makes it suitable for positron emission tomography (PET) imaging studies, where fluorinated pyridines are commonly used as tracers due to their favorable metabolic properties.

The agrochemical industry has also benefited from derivatives of 3-Bromo-5-fluoropyridine-2-carboxylic acid. Fluorinated pyridines are known for their efficacy in crop protection agents, exhibiting improved stability against environmental degradation while maintaining high selectivity toward pests. Researchers have synthesized novel herbicides and fungicides incorporating this scaffold, demonstrating its importance in sustainable agriculture. The bromo group further enables structural diversification, allowing chemists to optimize potency and selectivity through rational drug design approaches.

Advances in computational chemistry have further accelerated the use of 3-Bromo-5-fluoropyridine-2-carboxylic acid as a starting material. Machine learning models predict its reactivity patterns, helping researchers design synthetic routes with minimal trial-and-error experimentation. This high-throughput screening capability has been instrumental in identifying lead compounds for preclinical development. Collaborative efforts between academic institutions and pharmaceutical companies have led to innovative libraries of pyridine derivatives, many of which originate from this versatile intermediate.

The safety profile of 3-Bromo-5-fluoropyridine-2-carboxylic acid is another critical consideration in its application. While it is not classified as hazardous under standard conditions, proper handling protocols must be followed to prevent exposure during synthesis and purification. Industrial-scale production requires adherence to Good Manufacturing Practices (GMP) to ensure consistency and purity for downstream applications. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have guidelines for handling such intermediates in drug development pipelines.

Future directions in the research of 3-Bromo-5-fluoropyridine-2-carboxylic acid include exploring its role in next-generation therapeutics. Emerging fields such as immunotherapy and gene editing rely on sophisticated molecular tools that often incorporate fluorinated pyridines for improved functionality. By integrating this compound into novel drug candidates, scientists aim to address unmet medical needs with higher precision and fewer side effects. The growing interest in fluorinated heterocycles underscores their potential as key components in future medicines.

In conclusion, 3-Bromo-5-fluoropyridine-2-carboxylic acid (CAS No: 1189513-55-0) is a cornerstone intermediate with far-reaching implications across pharmaceuticals and agrochemicals. Its unique structural features enable diverse synthetic pathways, making it indispensable for medicinal chemists seeking innovative solutions to complex biological challenges. As research continues to uncover new applications for this compound, its significance in advancing therapeutic innovation is undeniable.

• 61830-12-4(2,6-Pyridinedicarboxylic acid, 3,5-dibromo-)
• 61830-40-8(3,5-Dibromopicolinic acid)
• 1211589-43-3(3-bromo-6-fluoro-pyridine-2-carboxylic acid)
• 1189933-55-8(3-Bromopicolinic Acid Sodium Salt)
• 669066-91-5(5-Bromo-3-fluoropyridine-2-carboxylic acid)
• 30683-23-9(3-Bromopyridine-2-carboxylic acid)
• 779344-30-8(3-bromo-6-methylpyridine-2-carboxylic acid)
• 137778-20-2(5-bromo-6-methyl-pyridine-2-carboxylic acid)
• 1227603-05-5(3-bromo-5-fluoro-2-pyridinecarbaldehyde)
• 316808-10-3(3-Bromopyridine-2,6-dicarboxylic acid)